Laxotabs Tablets
Laxotabs Tablets : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL20076108T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- UNIMED SDN. BHD.
- Manufacturer
- Matxin Labs Pvt. Ltd.
- Importer
- UNIMED SDN. BHD.
- Registration date
- 2025-07-24
- Published validity end
- 2030-07-24
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Operculina turpethum | Operculina turpethum[75mg ,445 mg] | Not identified |
| Embelia ribes | Embelia ribes[40mg,445 mg] | Not identified |
| Cichorium intybus | Cichorium intybus[50mg ,445 mg] | Not identified |
| Cassia occidentalis | Cassia occidentalis[50mg,445 mg] | Not identified |
| Piper longum | Piper longum[25mg ,445 mg] | Not identified |
| Glycyrrhiza glabra | Glycyrrhiza glabra[35mg,445 mg] | Not identified |
| Cassia angustifolia | Cassia angustifolia[10mg ,445 mg] | Not identified |
| Phoenix dactylifera | Phoenix dactylifera[5mg,445 mg] | Not identified |
| Zingiber officinale | Zingiber officinale[30mg ,445 mg] | Not identified |
| Terminalia chebula | Terminalia chebula[40mg,445 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Operculina turpethum[75mg ,445 mg],Embelia ribes[40mg,445 mg],Cichorium intybus[50mg ,445 mg],Cassia occidentalis[50mg,445 mg],Piper longum[25mg ,445 mg],Glycyrrhiza glabra[35mg,445 mg],Cassia angustifolia[10mg ,445 mg],Phoenix dactylifera[5mg,445 mg],Zingiber officinale[30mg ,445 mg],Terminalia chebula[40mg,445 mg]
- Valid until
- 2030-07-24
- Registration date
- 2025-07-24
- Published description
- NATURAL PRODUCT
- Licence holder
- UNIMED SDN. BHD.
- Importer
- UNIMED SDN. BHD.
- Producer
- Matxin Labs Pvt. Ltd.
- Published name
- Laxotabs Tablets
- Published reference
- 201908282599T
- Registration number
- MAL20076108T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL20076108T
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.